I sort of agree.
It is not an obvious transition but most Aussie Bios are too small to carry a commercial only CEO - it's like a school thinking it can run with the Principal being a business manager only.
I think RH made a great transition and even the 2nd half of last year did a good job of investor relations but to a very limited audience. Unfortunately we are getting to 3-6 months past that run but as we have been saying hopefully they are just cranking out the science making great headway - it is just starting to feel like the other parts of the role are being forgotten - maybe it all gets fixed in the next month or 2 cause they have been so focused internally. The risk I am trying to identify is that they avoid the accusation of only bothering with shareholders when they need money - I think I have been very patient with this but it does require constant managing.
There will be no takeout at anything like a normal premium - when you have a major shareholder with a stake like the Hockings they set the staring price if there ever was a buyer and my thinking is they think in the hundreds of millions within 3 years. Like you say - gotta get the MCAP closer to that first.
- Forums
- ASX - By Stock
- The biggest problem with PYC
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

I sort of agree. It is not an obvious transition but most Aussie...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
2 | 16380 | 1.260 |
3 | 14380 | 1.255 |
3 | 103380 | 1.250 |
1 | 4000 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 1380 | 1 |
1.290 | 27010 | 3 |
1.295 | 25880 | 2 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online